实用医学杂志 ›› 2021, Vol. 37 ›› Issue (10): 1357-1360.doi: 10.3969/j.issn.1006⁃5725.2021.10.025

• 中医药现代化 • 上一篇    下一篇

益气消癥方配合周期疗法治疗子宫内膜异位症痛经的临床观察

许明桃,郑玮琳,梁雪芳,曹立幸,陈韵婷    

  1. 1 广州中医药大学第二附属医院,广东省中医院妇科(广州 510120);2 广州中医药大学第二临床医学院 (广州 510405

  • 出版日期:2021-05-25 发布日期:2021-05-25
  • 通讯作者: 梁雪芳 E⁃mail:liangxuefang2006@126.com
  • 基金资助:
    国家自然科学基金资助项目(编号:81574008);广东省中医药局科研项目基金资助项目(编号:20172077);广东省名老中医药专家传承工作室建设项目(编号:国中医药人教函[2018]134 号)

Clinical observation of Yiqi Xiaozheng prescription combined with cycle therapy in the treatment of endo⁃ metriosis dysmenorrhea 

XU Mingtao,ZHENG Weilin,LIANG Xuefang,CAO Lixing,CHEN Yunting.    

  1. The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Department of Gynecology,Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou 510120,China 

  • Online:2021-05-25 Published:2021-05-25
  • Contact: LIANG Xuefang E⁃mail:liangxuefang2006@126.com

摘要:

目的 探讨益气消癥方配合周期疗法治疗子宫内膜异位症痛经的临床疗效。方法 纳入气虚血瘀型子宫内膜异位症痛经患者50例,随机分为治疗组25例和对照组25例。治疗组给予益气消癥方配合周期疗法治疗,对照组给予妈富隆口服,两组均治疗3个月经周期。比较患者治疗前后痛经VAS评分、中医证候积分、血清CA125水平,检测肝肾功能,评价治疗的安全性。结果 (1)治疗后,两组患者的痛经VAS 评分较治疗前显著降低(P < 0.05),两组比较差异无统计学意义(P > 0.05);(2)两组患者的中医证候积分水 平较治疗前下降(P < 0.05),中医组的降低程度较对照组更明显(P > 0.05);(3)两组患者的血清CA125水平 与治疗前相比,差异无统计学意义(P > 0.05);(4)治疗过程中两组患者均未出现严重的不良反应和肝肾功 能异常情况。结论 益气消癥方配合周期疗法能有效缓解内异症患者的痛经症状,与西药妈富隆疗效相当,并能改善患者气虚血瘀证候,具有较高的安全性,为内异症痛经患者提供一种优化的中医治疗方法。


关键词:

益气消癥方, 子宫内膜异位症, 痛经, 周期疗法

Abstract: Objective To explore the clinical efficacy of Yiqi Xiaozheng prescription combined with cycle therapy in the treatment of endometriosis dysmenorrhea. Methods Fifty patients with endometriosis dysmenorrhea due to Qi deficiency and blood stasis were randomly divided into a treatment group(25 patients)and a control group(25 patients). The treatment group was given Yiqi Xiaozheng prescription combined with cycle therapy while the control group was given marvelon. Both groups were treated for 3 menstrual cycles. The VAS score of dysmenorrhea,TCM syndrome score,and serum CA125 level were compared before and after treatment,liver and kidney function were detected,and the safety of treatment was evaluated. Results After treatment,the dysmenor⁃ rhea VAS scores were significantly lower in the two groups(P<0.05),and there was no significant difference between the two groups(> 0.05). The TCM syndrome scores in the two groups were lower than the baseline scores(< 0.05),and the decline level was more obvious in the treatment group than in the control group(> 0.05). There was no significant difference in serum CA125 level between the two groups as compared with the base⁃ line level(> 0.05). There were no serious adverse reactions and abnormal liver and kidney function in the two groups during the treatment. Conclusions Yiqi Xiaozheng prescription combined with cycle therapy can effectively relieve dysmenorrhea in patients with endometriosis,which has the same efficacy as the Western medicine marvel⁃ on. It can improve the syndrome of Qi deficiency and blood stasis and has higher safety,providing an optimized TCM treatment method for patients with endometriosis dysmenorrhea. 

Key words:

Yiqi Xiaozheng prescription, endometriosis, dysmenorrhea, cycle therapy